Sungmi Park
Overview
Explore the profile of Sungmi Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
664
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Min B, Park S, Kang H, Kim D, Ham H, Ha C, et al.
Front Immunol
. 2019 May;
10:944.
PMID: 31134063
Metabolic reprogramming during macrophage polarization supports the effector functions of these cells in health and disease. Here, we demonstrate that pyruvate dehydrogenase kinase (PDK), which inhibits the pyruvate dehydrogenase-mediated conversion...
12.
Lee D, Pagire H, Pagire S, Bae E, Dighe M, Kim M, et al.
J Med Chem
. 2019 Feb;
62(5):2849.
PMID: 30811938
No abstract available.
13.
Park S, Kang H, Jeon J, Kim M, Lee I
Arch Pharm Res
. 2019 Feb;
42(3):252-262.
PMID: 30771210
Millions of people worldwide have diabetes, which is diagnosed by fasting blood glucose levels exceeding 126 mg/dL. Regardless of the type of diabetes, prolonged hyperglycemia is damaging to several organs...
14.
Lee D, Pagire H, Pagire S, Bae E, Dighe M, Kim M, et al.
J Med Chem
. 2019 Jan;
62(2):575-588.
PMID: 30623649
Pyruvate dehydrogenase kinase 4 (PDK4) activation is associated with metabolic diseases including hyperglycemia, insulin resistance, allergies, and cancer. Structural modifications of hit anthraquinone led to the identification of a new...
15.
Park S, Jeon J, Min B, Ha C, Thoudam T, Park B, et al.
Diabetes Metab J
. 2018 Aug;
42(4):270-281.
PMID: 30136450
Mitochondrial dysfunction is a hallmark of metabolic diseases such as obesity, type 2 diabetes mellitus, neurodegenerative diseases, and cancers. Dysfunction occurs in part because of altered regulation of the mitochondrial...
16.
Park S, Bivona B, Harrison-Bernard L
Am J Physiol Renal Physiol
. 2018 Feb;
314(6):F1197-F1204.
PMID: 29412691
We have previously reported significant increases in neuronal nitric oxide synthase (NOS) immunostaining in renal arterioles of angiotensin type 1A receptor (AT1A) knockout mice, and in arterioles and macula densa...
17.
Lee Y, Ha C, Kim S, Thoudam T, Yoon Y, Kim D, et al.
Diabetes
. 2017 Jul;
66(10):2669-2680.
PMID: 28720696
Low-dose persistent organic pollutants (POPs), especially organochlorine pesticides (OCPs) and polychlorinated biphenyls (PCBs), have emerged as a new risk factor for type 2 diabetes. We evaluated whether chronic exposure to...
18.
Oh C, Ha C, Choi Y, Park S, Choe M, Jeoung N, et al.
Kidney Int
. 2017 Jan;
91(4):880-895.
PMID: 28040265
Clinical prescription of cisplatin, one of the most widely used chemotherapeutic agents, is limited by its side effects, particularly tubular injury-associated nephrotoxicity. Since details of the underlying mechanisms are not...
19.
Choi S, Leem J, Park S, Lee C, Park K, Lee I
Can J Physiol Pharmacol
. 2016 Dec;
95(2):129-139.
PMID: 27918207
Dipeptidyl peptidase 4 (DPP-4) inhibitors are widely used antihyperglycemic agents for type 2 diabetes mellitus. Recently, increasing attention has been focused on the pleiotropic actions of DPP-4 inhibitors. The aim...
20.
Littlejohn N, Keen H, Weidemann B, Claflin K, Tobin K, Markan K, et al.
Cell Rep
. 2016 Aug;
16(6):1548-1560.
PMID: 27477281
Activation of the brain renin-angiotensin system (RAS) stimulates energy expenditure through increasing of the resting metabolic rate (RMR), and this effect requires simultaneous suppression of the circulating and/or adipose RAS....